Enzo Biochem (NY: ENZ )

3.060 USD +0.070 (+2.34%)

Official Closing Price Updated: 7:59 PM EST, Jan 22, 2021 Add to My Watchlist

Price and Volume

Volume	290,500
Open	2.980
Bid (Size)	3.060 (18)
Ask (Size)	3.200 (9)
Prev. Close	2.990
Today's Range	2.937 - 3.060
52wk Range	1.560 - 4.850
Shares Outstanding	47,165,942
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

ENZO BIOCHEM’S BOARD OF DIRECTORS FORMS NEW CORPORATE DEVELOPMENT AND PLANNING & SUCCESSION COMMITTEES

January 20, 2021

Roumell Announces Preliminary Annual Meeting Results for Enzo Biochem, Inc.

January 05, 2021

At a Minimum, Chairman and CEO, Dr. Elazar Rabbani, Must Tender His Resignation from the Board According to Roumell's Initial Tabulations

Performance

YTD	+15.04%	+15.04%
1 Month	+31.33%	+31.33%
3 Month	+45.71%	+45.71%
6 Month	+27.50%	+27.50%
1 Year	+20.00%	+20.00%

More News

ENZO BIOCHEM TO PARTICIPATE IN THE LIFESCI PARTNERS 10TH ANNUAL HEALTHCARE CORPORATE ACCESS EVENT

January 05, 2021

ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR TESTING POOLED SAMPLES ON THREE PLATFORMS INCLUDING COMPANY’S GENFLEX™ PROPRIETARY SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2

January 04, 2021

Leading Proxy Advisory Firms, Institutional Shareholder Services and Glass Lewis, Recommend That Shareholders Vote AGAINST Elazar Rabbani at Enzo's Upcoming Annual Meeting

December 31, 2020

ENZO RESPONDS AFTER REVIEWING THE POSITION OF INSTITUTIONAL SHAREHOLDER SERVICES

December 28, 2020

Roumell Asset Management Files Definitive Proxy Statement and Sends Letter to Enzo Biochem Shareholders

December 24, 2020

Enzo Biochem Hosting Key Opinion Leader Call on GENFLEX™ Molecular System for COVID-19 and the Role of Testing in a Post-Vaccine Treatment Environment

December 15, 2020

Enzo Biochem Reports First Quarter Fiscal 2021 Financial Results and Provides Business Update

December 09, 2020

Enzo Biochem to Report First Quarter 2021 Financial Results on Wednesday, December 9

December 02, 2020

ENZO BIOCHEM ANNOUNCES APPOINTMENT OF IAN B. WALTERS, MD, TO ITS BOARD OF DIRECTORS

November 25, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.